We are live on ! Find out more
HA

HC Advisors Portfolio holdings

AUM $149M
1-Year Est. Return 17.72%
This Fund
S&P 500
This Quarter Est. Return
+5.54%
1 Year Est. Return
+17.72%
3 Year Est. Return
+55.19%
5 Year Est. Return
+59.33%
10 Year Est. Return
AUM
$163M
AUM Growth
+$7.83M
Cap. Flow
-$52.4K
Cap. Flow %
-0.03%
Top 10 Hldgs %
63.24%
Holding
93
New
4
Increased
33
Reduced
24
Closed
11

Sector Composition

Rank Sector Weight
1 Technology 2.65%
2 Financials 2.61%
3 Healthcare 2.44%
4 Consumer Discretionary 1.28%
5 Materials 1.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
APLS
76
DELISTED
Apellis Pharmaceuticals
APLS
$209K 0.13%
3,310
-2,213
-40% -$114K
SGDM icon
77
Sprott Gold Miners ETF
SGDM
$542M
$209K 0.13%
+7,393
New +$224K
NGD
78
DELISTED
New Gold Inc
NGD
$193K 0.12%
106,800
+21,100
+25% +$39.8K
EQX icon
79
Equinox Gold
EQX
$7.07B
$176K 0.11%
25,392
+8,381
+49% +$71.6K
PASG icon
80
Passage Bio
PASG
$14.5M
$144K 0.09%
546
+34
+7% +$10.5K
TINV.WS
81
DELISTED
Tiga Acquisition Corp. Warrants, each warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
TINV.WS
$60K 0.04%
53,861
+14,481
+37% +$15.9K
KSMTW
82
DELISTED
Kismet Acquisition One Corp Warrant
KSMTW
$21K 0.01%
17,100
+900
+6% +$703
BDTX icon
83
Black Diamond Therapeutics
BDTX
$95.1M
-8,330
Closed -$202K
BX icon
84
Blackstone
BX
$104B
-2,641
Closed -$197K
CMCSA icon
85
Comcast
CMCSA
$87.3B
-4,236
Closed -$229K
CVX icon
86
Chevron
CVX
$382B
-1,962
Closed -$206K
CYTK icon
87
Cytokinetics
CYTK
$10.6B
-9,009
Closed -$210K
ESGV icon
88
Vanguard ESG US Stock ETF
ESGV
$12.8B
-3,000
Closed -$221K
GE icon
89
GE Aerospace
GE
$364B
-2,125
Closed -$139K
GPC icon
90
Genuine Parts
GPC
$17.9B
-1,738
Closed -$201K
PLRX icon
91
Pliant Therapeutics
PLRX
$65M
-5,493
Closed -$216K
PM icon
92
Philip Morris
PM
$309B
-2,241
Closed -$199K
T icon
93
AT&T
T
$164B
-8,546
Closed -$195K

Similar funds

HC Advisors's Q2 2021 Portfolio in Review

As of Q2 2021, HC Advisors held 93 positions worth $163M, up 5.1% from $155M the previous quarter. Its ten largest holdings account for 63% of the portfolio.

HC Advisors's Q2 2021 filing shows 4 new, 33 increased, 24 reduced and 11 closed positions. Its largest new stake was Eli Lilly: 3,268 shares worth $750K. The largest sale was iShares US Financials ETF, an estimated $306K.

By sector, the portfolio is most concentrated in Technology at 2.7% of assets, up from 2.6% a quarter earlier, followed by Financials and Healthcare.

  • HC Advisors's largest Q2 2021 buy was Eli Lilly: 3,268 shares worth $750K.
  • HC Advisors added most to Vanguard Morningstar Total Stock Market ETF in Q2 2021, an estimated $478K increase.
  • HC Advisors's biggest Q2 2021 reduction was iShares US Financials ETF, cutting an estimated $306K.
  • HC Advisors fully exited Comcast in Q2 2021, selling an estimated $229K.
  • HC Advisors's ten largest holdings make up 63% of its $163M portfolio in Q2 2021.
  • HC Advisors opened 4 new positions and closed 11 in Q2 2021.
  • HC Advisors's portfolio value rose 5.1% quarter-over-quarter to $163M.

Based on HC Advisors's 13F filing for Q2 2021, filed 9 Aug 2021.